News & Articles

SelectScience will be attending the AACC Annual Meeting in Chicago, USA, to interview leading scientists and report on the latest technologies

The findings could help clinicians decide the best course and delivery of treatment for cancer patients

Breakthrough research of faecal metabolites could lead to personalized obesity treatments within a decade

The immunoassay is the market’s first validated high-performance multiplex screening panel

The test will expand the range of diagnostic options available to guide the treatment of Plasmodium vivax

Boosting T cell memory may result in long-lasting and effective responses for patients treated with checkpoint blockade immunotherapies

CYC065, an inhibitor of CDK2 and CDK9 kinases, has inhibited tumor growth in some patients with advanced cancers

During the American Association for Cancer Research 2018 Annual Meeting, SelectScience recognized cutting-edge products and technologies advancing life sciences research

The trial demonstrates that first-line pembrolizumab treatment improved overall and progression-free survival rates in patients with metastatic nonsquamous non-small cell lung cancer

The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer

Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer

A recent study from University of Edinburgh aims to pinpoint genes that may be associated with depression